Presenilin

Error creating thumbnail:

6idf psen1 notch blue asp

Presenilin is a family of proteins that play a crucial role in the development and function of neurons. Presenilins are best known for their involvement in the processing of amyloid precursor protein (APP), a process that is central to the pathogenesis of Alzheimer's disease. There are two main presenilin proteins found in humans: Presenilin 1 (PSEN1) and Presenilin 2 (PSEN2), encoded by the PSEN1 and PSEN2 genes, respectively.

Function

Presenilins are integral components of the gamma-secretase complex, an enzyme responsible for cleaving several type I transmembrane proteins, including APP. The cleavage of APP by gamma-secretase produces beta-amyloid (Aβ) peptides, which can aggregate to form amyloid plaques, a hallmark of Alzheimer's disease pathology. In addition to their role in APP processing, presenilins are involved in the regulation of calcium signaling, neuronal development, and cell death processes.

Genetics

Mutations in the PSEN1 and PSEN2 genes are linked to early-onset familial Alzheimer's disease (EOFAD), a rare form of Alzheimer's that typically manifests before the age of 65. These mutations lead to alterations in the gamma-secretase's activity, resulting in the increased production of the more aggregation-prone forms of Aβ peptides, such as Aβ42, which is strongly associated with the development of Alzheimer's disease.

Structure

Presenilins are transmembrane proteins that contain several hydrophobic regions, allowing them to be embedded within the cell membrane. They function as part of the larger gamma-secretase complex, which also includes nicastrin, APH-1, and PEN-2. This complex is vital for the proteolytic activities of presenilins and is involved in the cleavage of numerous substrates besides APP.

Clinical Significance

The link between presenilin mutations and Alzheimer's disease highlights the importance of these proteins in neuronal health and disease. Understanding the precise mechanisms by which presenilin mutations lead to Alzheimer's disease can aid in the development of targeted therapies. Currently, there is no cure for Alzheimer's, but treatments that can modulate gamma-secretase activity or reduce Aβ production are under investigation.

Research Directions

Research on presenilins continues to explore their broader role in cellular processes beyond APP processing. This includes studies on their involvement in cell signaling pathways, membrane trafficking, and the regulation of gene expression. Insights into these areas may provide new therapeutic targets for Alzheimer's disease and other conditions associated with presenilin dysfunction.